2nd Quarter - Report

LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION

Firm
Client
Income
—
Expenses
$210,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests.

LobbyistCovered position, as disclosed
AMY MUHLBERG N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Synthetic Biology Research and Advancement Act (No bill number to date); Provisions regarding DNA synthesizer certification.

LobbyistCovered position, as disclosed
AMY MUHLBERG N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Law Enforcement/Crime/Criminal Justice LAW

H.R.988/ S.517: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 517 (112th), H.R. 988 (112th)

Copyright/Patent/Trademark CPT

H.R. 1056: Patent Continuing Disclosure Act; All provisions of the bill. H.R. 1249: Leahy-Smith America Invents Act; Provisions regarding false markings, virtual marking first to file, post grant review and inequitable conduct.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1056 (112th), H.R. 1249 (112th)

Budget/Appropriations BUD

Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12 (No Bill Number to date); Provisions regarding National Institutes of Health funding. H.R. 1363: Department of Defense and Further Additional Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding. H.R. 1473: Department of Defense and Full Year Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding, biosurveillance programs and appropriations for forensic DNA.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A
AMY MUHLBERG N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1363 (112th), H.R. 1473 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.